Neurobiology of Aging
Volume 29, Issue 7 , Pages 1027-1039 , July 2008

Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease

  • Thomas P. Bouchard

      Affiliations

    • Department of Medicine (Neurology), University of Alberta, 10230, 111th Avenue, Edmonton, Alberta, Canada T5R 0B7
    • ,
  • Nikolai Malykhin

      Affiliations

    • Department of Psychiatry, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • W.R. Wayne Martin

      Affiliations

    • Department of Medicine (Neurology), University of Alberta, 10230, 111th Avenue, Edmonton, Alberta, Canada T5R 0B7
    • ,
  • Christopher C. Hanstock

      Affiliations

    • Department of Biomedical Engineering, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Derek J. Emery

      Affiliations

    • Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Nancy J. Fisher

      Affiliations

    • Division of Neurosciences, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Richard M. Camicioli

      Affiliations

    • Department of Medicine (Neurology), University of Alberta, 10230, 111th Avenue, Edmonton, Alberta, Canada T5R 0B7
    • Corresponding Author InformationCorresponding author. Tel.: +1 780 735 8840; fax: +1 780 735 8804.

Received 11 September 2006 ,Revised 29 January 2007 ,Accepted 5 February 2007.

References 

  1. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch. Neurol. 2003;60:387–392
  2. Aarsland D, Perry R, Brown A, Larsen JP, Ballard C. Neuropathology of dementia in Parkinson's disease: a prospective, community-based study. Ann. Neurol. 2005;58:773–776
  3. Allen JS, Bruss J, Brown CK, Damasio H. Normal neuroanatomical variation due to age: the major lobes and a parcellation of the temporal region. Neurobiol. Aging. 2005;26:1245–1260(discussion 1279–1282)
  4. Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch. Neurol. 2002;59:102–112
  5. Ariza M, Serra-Grabulosa JM, Junque C, Ramirez B, Mataro M, Poca A, et al. Hippocampal head atrophy after traumatic brain injury. Neuropsychologia. 2006;44:1956–1961
  6. Baldereschi M, Di Carlo A, Rocca WA, Vanni P, Maggi S, Perissinotto E, et al. Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology. 2000;55:1358–1363
  7. Barber R, Ballard C, McKeith IG, Gholkar A, O’Brien JT. MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia. Neurology. 2000;54:1304–1309
  8. Basso M, Yang J, Warren L, MacAvoy MG, Varma P, Bronen RA, et al. Volumetry of amygdala and hippocampus and memory performance in Alzheimer's disease. Psychiatr. Res. 2006;146:251–261
  9. Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 2006;66:1837–1844
  10. Bernasconi N, Bernasconi A, Caramanos Z, Antel SB, Andermann F, Arnold DL. Mesial temporal damage in temporal lobe epilepsy: a volumetric MRI study of the hippocampus, amygdala and parahippocampal region. Brain. 2003;126:462–469
  11. Braak H, Rub U, Jansen Steur EN, Del Tredici K, de Vos RA. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology. 2005;64:1404–1410
  12. Braak H, Tredici KD, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging. 2003;24:197–211
  13. Brown GG, Rahill AA, Gorell JM, McDonald C, Brown SJ, Sillanpaa M, et al. Validity of the dementia rating scale in assessing cognitive function in Parkinson's disease. J. Geriatr. Psychiatr. Neurol. 1999;12:180–188
  14. Bruck A, Kurki T, Kaasinen V, Vahlberg T, Rinne JO. Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment. J. Neurol. Neurosurg. Psychiatry. 2004;75:1467–1469
  15. Burn DJ, Rowan EN, Allan LM, Molloy S, O’Brien JT, McKeith IG. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J. Neurol. Neurosurg. Psychiatry. 2006;77:585–589
  16. Burton EJ, Karas G, Paling SM, Barber R, Williams ED, Ballard CG, et al. Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. Neuroimage. 2002;17:618–630
  17. Burton EJ, McKeith IG, Burn DJ, O’Brien JT. Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging. Mov. Disord. 2005;20:1571–1576
  18. Burton EJ, McKeith IG, Burn DJ, Williams ED. JT OB Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain. 2004;127:791–800
  19. Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA. Parkinson's disease is associated with hippocampal atrophy. Mov. Disord. 2003;18:784–790
  20. Camicioli RM, Korzan JR, Foster SL, Fisher NJ, Emery DJ, Bastos AC, et al. Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia. Neurosci. Lett. 2004;354:177–180
  21. Churchyard A, Lees AJ. The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease. Neurology. 1997;49:1570–1576
  22. Cohen RM, Szczepanik J, McManus M, Mirza N, Putnam K, Levy J, et al. Hippocampal atrophy in the healthy is initially linear and independent of age. Neurobiol. Aging. 2006;27:1385–1394
  23. Cordato NJ, Halliday GM, Harding AJ, Hely MA, Morris JG. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease. Ann. Neurol. 2000;47:718–728
  24. Cordato NJ, Pantelis C, Halliday GM, Velakoulis D, Wood SJ, Stuart GW, et al. Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. Brain. 2002;125:789–800
  25. Davidson PS, Anaki D, Saint-Cyr JA, Chow TW, Moscovitch M. Exploring the recognition memory deficit in Parkinson's disease: estimates of recollection versus familiarity. Brain. 2006;129:1768–1779
  26. den Heijer T, Geerlings MI, Hoebeek FE, Hofman A, Koudstaal PJ, Breteler MM. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people. Arch. Gen. Psychiatry. 2006;63:57–62
  27. Double KL, Halliday GM, McRitchie DA, Reid WG, Hely MA, Morris JG. Regional brain atrophy in idiopathic Parkinson's disease and diffuse Lewy body disease. Dementia. 1996;7:304–313
  28. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology. 2000;55:1621–1626
  29. Duvernoy H. The Human Hippocampus: Functional Anatomy, Vascularization and Serial Sections with MRI. 2nd ed.. Berlin: Springer-Verlag; 1998;
  30. Eritaia J, Wood SJ, Stuart GW, Bridle N, Dudgeon P, Maruff P, et al. An optimized method for estimating intracranial volume from magnetic resonance images. Magn. Reson. Med. 2000;44:973–977
  31. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12:189–198
  32. Galvin JE, Pollack J, Morris JC. Clinical phenotype of Parkinson disease dementia. Neurology. 2006;67:1605–1611
  33. Gancher ST. Scales for the assessment of movement disorders. In:  Herndon RM editors. Handbook of Neurologic Rating Scales. New York: Demos Vermande; 1997;p. 81–106
  34. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 1988;51:745–752
  35. Hackert VH, den Heijer T, Oudkerk M, Koudstaal PJ, Hofman A, Breteler MM. Hippocampal head size associated with verbal memory performance in nondemented elderly. Neuroimage. 2002;17:1365–1372
  36. Harding AJ, Stimson E, Henderson JM, Halliday GM. Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. Brain. 2002;125:2431–2445
  37. Hashimoto M, Kitagaki H, Imamura T, Hirono N, Shimomura T, Kazui H, et al. Medial temporal and whole-brain atrophy in dementia with Lewy bodies: a volumetric MRI study. Neurology. 1998;51:357–362
  38. Hedges LV, Olkin I. Statistical Methods for Meta-Analysis. Orlando: Academic Press; 1985;
  39. Hobson DE, Lang AE, Martin WR, Razmy A, Rivest J, Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA. 2002;287:455–463
  40. Hobson P, Meara J. Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom. Mov. Disord. 2004;19:1043–1049
  41. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427–442
  42. Hu MT, White SJ, Chaudhuri KR, Morris RG, Bydder GM, Brooks DJ. Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline. J. Neural. Transm. 2001;108:571–580
  43. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology. 2001;57:1497–1499
  44. Hughes TA, Ross HF, Musa S, Bhattacherjee S, Nathan RN, Mindham RH, et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology. 2000;54:1596–1602
  45. Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, et al. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology. 2000;54:1916–1921
  46. Jack CR, Petersen RC, Xu Y, O’Brien PC, Smith GE, Ivnik RJ, et al. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology. 1998;51:993–999
  47. Jack CR, Petersen RC, Xu YC, Waring SC, O’Brien PC, Tangalos EG, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology. 1997;49:786–794
  48. Joelving FC, Billeskov R, Christensen JR, West M, Pakkenberg B. Hippocampal neuron and glial cell numbers in Parkinson's disease—a stereological study. Hippocampus. 2006;16:826–833
  49. Junque C, Ramirez-Ruiz B, Tolosa E, Summerfield C, Marti MJ, Pastor P, et al. Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia. Mov. Disord. 2005;20:540–544
  50. Kassubek J, Juengling FD, Hellwig B, Spreer J, Lucking CH. Thalamic gray matter changes in unilateral Parkinsonian resting tremor: a voxel-based morphometric analysis of 3-dimensional magnetic resonance imaging. Neurosci. Lett. 2002;323:29–32
  51. Kopelman MD, Bright P, Buckman J, Fradera A, Yoshimasu H, Jacobson C, et al. Recall and recognition memory in amnesia: Patients with hippocampal, medial temporal, temporal lobe or frontal pathology. Neuropsychologia. 2007;45:1232–1246
  52. Laakso MP, Partanen K, Lehtovirta M, Hallikainen M, Hanninen T, Vainio P, et al. MRI of amygdala fails to diagnose early Alzheimer's disease. Neuroreport. 1995;6:2414–2418
  53. Laakso MP, Partanen K, Riekkinen P, Lehtovirta M, Helkala EL, Hallikainen M, et al. Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: an MRI study. Neurology. 1996;46:678–681
  54. Levy G, Jacobs DM, Tang MX, Cote LJ, Louis ED, Alfaro B, et al. Memory and executive function impairment predict dementia in Parkinson's disease. Mov. Disord. 2002;17:1221–1226
  55. Levy G, Tang MX, Cote LJ, Louis ED, Alfaro B, Mejia H, et al. Motor impairment in PD: relationship to incident dementia and age. Neurology. 2000;55:539–544
  56. Lippa CF, Morris JC. Alzheimer neuropathology in nondemented aging: keeping mind over matter. Neurology. 2006;66:1801–1802
  57. Maller JJ, Reglade-Meslin C, Anstey KJ, Sachdev P. Sex and symmetry differences in hippocampal volumetrics: before and beyond the opening of the crus of the fornix. Hippocampus. 2006;16:80–90
  58. Malykhin, N., Bouchard, T.P., Ogilvie, C.J., Seres, P., Coupland, N.J., Camicioli, R., in press. Three-dimensional volumetric analysis and reconstruction of amygdala and hippocampal head, body and tail. Psychiatr. Res. Neuroim.
  59. Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, et al. beta-Amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc. Natl. Acad. Sci. USA. 2001;98:12245–12250
  60. Mattila PM, Koskela T, Roytta M, Lehtimaki T, Pirttila TA, Ilveskoski E, et al. Apolipoprotein E epsilon4 allele frequency is increased in Parkinson's disease only with co-existing Alzheimer pathology. Acta Neuropathol. (Berl.). 1998;96:417–420
  61. Mattila PM, Rinne JO, Helenius H, Roytta M. Neuritic degeneration in the hippocampus and amygdala in Parkinson's disease in relation to Alzheimer pathology. Acta Neuropathol. (Berl.). 1999;98:157–164
  62. Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology. 1993;43:2412–2414
  63. Mu Q, Xie J, Wen Z, Weng Y, Shuyun Z. A quantitative MR study of the hippocampal formation, the amygdala, and the temporal horn of the lateral ventricle in healthy subjects 40 to 90 years of age. Am. J. Neuroradiol. 1999;20:207–211
  64. Mueller EA, Moore MM, Kerr DC, Sexton G, Camicioli RM, Howieson DB, et al. Brain volume preserved in healthy elderly through the eleventh decade. Neurology. 1998;51:1555–1562
  65. Nagano-Saito A, Washimi Y, Arahata Y, Kachi T, Lerch JP, Evans AC, et al. Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology. 2005;64:224–229
  66. O’Brien JT, Desmond P, Ames D, Schweitzer I, Tress B. Magnetic resonance imaging correlates of memory impairment in the healthy elderly: association with medial temporal lobe atrophy but not white matter lesions. Int. J. Geriatr. Psychiatry. 1997;12:369–374
  67. Parmelee PA, Thuras PD, Katz IR, Lawton MP. Validation of the cumulative illness rating scale in a geriatric residential population. J. Am. Geriatr. Soc. 1995;43:130–137
  68. Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain. 2006;129:1040–1049
  69. Pennanen C, Testa C, Boccardi M, Laakso MP, Hallikainen M, Helkala EL, et al. The effect of apolipoprotein polymorphism on brain in mild cognitive impairment: a voxel-based morphometric study. Dement. Geriatr. Cogn. Disord. 2006;22:60–66
  70. Pruessner JC, Collins DL, Pruessner M, Evans AC. Age and gender predict volume decline in the anterior and posterior hippocampus in early adulthood. J. Neurosci. 2001;21:194–200
  71. Pruessner JC, Li LM, Serles W, Pruessner M, Collins DL, Kabani N, et al. Volumetry of hippocampus and amygdala with high-resolution MRI and three-dimensional analysis software: minimizing the discrepancies between laboratories. Cereb. Cortex. 2000;10:433–442
  72. Ramirez-Ruiz B, Marti MJ, Tolosa E, Bartres-Faz D, Summerfield C, Salgado-Pineda P, et al. Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia. J. Neurol. 2005;252:1345–1352
  73. Raz N, Gunning-Dixon F, Head D, Rodrigue KM, Williamson A, Acker JD. Aging, sexual dimorphism, and hemispheric asymmetry of the cerebral cortex: replicability of regional differences in volume. Neurobiol. Aging. 2004;25:377–396
  74. Spreen O, Strauss E. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. 2nd ed.. New York: Oxford University Press; 1998;
  75. Summerfield C, Junque C, Tolosa E, Salgado-Pineda P, Gomez-Anson B, Marti MJ, et al. Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch. Neurol. 2005;62:281–285
  76. Tam CW, Burton EJ, McKeith IG, Burn DJ, O’Brien JT. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Neurology. 2005;64:861–865
  77. Van Petten C. Relationship between hippocampal volume and memory ability in healthy individuals across the lifespan: review and meta-analysis. Neuropsychologia. 2004;42:1394–1413
  78. Weintraub D, Oehlberg KA, Katz IR, Stern MB. Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease. Am. J. Geriatr. Psychiatry. 2006;14:169–175
  79. Whittington CJ, Podd J, Kan MM. Recognition memory impairment in Parkinson's disease: power and meta-analyses. Neuropsychology. 2000;14:233–246
  80. Whittington CJ, Podd J, Stewart-Williams S. Memory deficits in Parkinson's disease. J. Clin. Exp. Neuropsychol. 2006;28:738–754
  81. Wixted JT, Squire LR. Recall and recognition are equally impaired in patients with selective hippocampal damage. Cogn. Affect. Behav. Neurosci. 2004;4:58–66
  82. Woods SP, Troster AI. Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson's disease. J. Int. Neuropsychol. Soc. 2003;9:17–24
  83. Yesavage JA. Geriatric depression scale. Psychopharmacol. Bull. 1988;24:709–711

☆ The authors have no competing interests. The study was approved by the University of Alberta's Health Ethics review board, and informed consent was obtained from all participants.

PII: S0197-4580(07)00042-5

doi: 10.1016/j.neurobiolaging.2007.02.002

Neurobiology of Aging
Volume 29, Issue 7 , Pages 1027-1039 , July 2008

Article Tools

* Image Usage & Resolution